Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Singapore
  4. Singapore Stock Exchange
  5. Singapore Medical Group Limited
  6. News
  7. Summary
    5OT   SG1Y37945678

SINGAPORE MEDICAL GROUP LIMITED

(5OT)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Asset Acquisitions and Disposals::PROPOSED ACQUISITION OF SMG INTERNATIONAL (VIETNAM) PTE. LTD. - RECEIPT LISTING AND QUOTATION NOTICE

09/01/2021 | 12:42am EST

SINGAPORE MEDICAL GROUP LIMITED

(Company Registration No.: 200503187W)

PROPOSED ACQUISITION OF SHARES IN SMG INTERNATIONAL (VIETNAM) PTE. LTD.

  • RECEIPT OF LISTING AND QUOTATION NOTICE IN RESPECT OF THE CONSIDERATION SHARES
  1. INTRODUCTION
    The Board of Directors (the "Board") of Singapore Medical Group Limited (the "Company") refers to the announcement dated 19 August 2021 (the "Earlier Announcement") in relation to the proposed acquisition of 850,000 issued and fully paid ordinary shares representing the remaining 50% of the issued and paid up share capital in SMG International (Vietnam) Pte. Ltd. (the "Proposed Acquisition"), under which 3,398,203 new ordinary shares in the share capital of the Company (the "Consideration Shares") are to be issued and allotted to certain Vendors as part of the consideration payable under the Proposed Acquisition.
    All capitalised terms used and not defined herein shall have the same meanings given to them in the Earlier Announcement.
  2. RECEIPT OF LISTING AND QUOTATION NOTICE
    Further to the Earlier Announcement, the Board is pleased to announce that the Company has, on 31 August 2021, received the listing and quotation notice ("LQN") from the SGX-ST for the listing and quotation of the Consideration Shares on the Catalist, subject to compliance with the SGX-ST's listing requirements.
    The LQN is not to be taken as an indication of the merits of the Proposed Acquisition, the Consideration Shares, the Company, its subsidiaries and their securities.
    The Company will make the necessary announcement(s) on the Proposed Acquisition as appropriate or when there are further developments on the same.

By Order of the Board

Beng Teck Liang

Executive Director and Chief Executive Officer

1 September 2021

This announcement has been prepared by Singapore Medical Group Limited (the "Company") and its contents have been reviewed by the Company's sponsor, UOB Kay Hian Private Limited (the "Sponsor") for compliance with the relevant rules of the Singapore Exchange Securities Trading Limited ("SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Mr Lance Tan, Senior Vice President, at 8 Anthony Road, #01- 01, Singapore 229957, telephone (65) 6590 6881.

1

Disclaimer

Singapore Medical Group Limited published this content on 01 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 September 2021 04:41:03 UTC.


ę Publicnow 2021
All news about SINGAPORE MEDICAL GROUP LIMITED
10/27Singapore Medical Group Links Up with Aurum Land to Launch Medical Coworking Space
MT
10/27Singapore Medical Group and Aurum Land Pte Ltd Ink Joint Venture Agreement to Introduce..
CI
09/13SINGAPORE MEDICAL : Closes $2 Million Takeover of Vietnamese Joint Venture
MT
09/13ASSET ACQUISITIONS AND DISPOSALS : :completion of the acquisition of shares in smg interna..
PU
09/13Singapore Medical Group Limited completed the acquisition of remaining 50% stake in SMG..
CI
09/01Singapore Medical Gets Bourse Approval on $2 Million Takeover of Vietnamese JV
MT
09/01ASSET ACQUISITIONS AND DISPOSALS : :proposed acquisition of smg international (vietnam) pt..
PU
08/19Singapore Medical Group Limited entered into a sale and purchase agreement to acquire r..
CI
08/02SINGAPORE MEDICAL : Attributable Profit Doubles in H1
MT
08/02Singapore Medical Group Limited Reports Earnings Results for the Half Year Ended June 3..
CI
More news
Financials
Sales 2021 93,0 M 68,1 M 68,1 M
Net income 2021 14,0 M 10,3 M 10,3 M
Net Debt 2021 - - -
P/E ratio 2021 10,9x
Yield 2021 -
Capitalization 148 M 109 M 109 M
Capi. / Sales 2021 1,60x
Capi. / Sales 2022 1,37x
Nbr of Employees 294
Free-Float 49,4%
Chart SINGAPORE MEDICAL GROUP LIMITED
Duration : Period :
Singapore Medical Group Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINGAPORE MEDICAL GROUP LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 0,31 SGD
Average target price 0,48 SGD
Spread / Average Target 57,4%
EPS Revisions
Managers and Directors
Beng Teck Liang Chief Executive Officer & Executive Director
Sian Jing Wong Chief Financial Officer
Choon Keat Tan Non-Executive Chairman
Carolyn Goh Director-Information Technology Operations
Wing Kuen Yim Independent Director
Sector and Competitors